Jul 21, 2025 08:28AM ImmunoPrecise appoints healthcare data expert Jeff Fried to advisory board

Jul 14, 2025 08:01AM ImmunoPrecise regains Nasdaq compliance with minimum bid price

Jul 7, 2025 09:00AM ImmunoPrecise adds Jon Lieber to board of directors

Jun 13, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Immunoprecise Antibodies Ltd. (IPA)

Jun 12, 2025 08:18AM ImmunoPrecise Antibodies (IPA): AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies

Jun 5, 2025 08:01AM ImmunoPrecise Antibodies (IPA) Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery

Apr 14, 2025 06:55AM H.C. Wainwright Reiterates Buy Rating on Immunoprecise Antibodies Ltd. (IPA)

Apr 1, 2025 09:35AM Benchmark Reiterates Speculative Buy Rating on Immunoprecise Antibodies Ltd. (IPA)

Mar 31, 2025 06:40AM Immunoprecise Antibodies Ltd. (IPA) PT Lowered to $5 at H.C. Wainwright

Mar 13, 2025 07:02AM ImmunoPrecise Antibodies (IPA) and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics

Feb 26, 2025 08:05AM ImmunoPrecise Antibodies (IPA) and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy

Feb 24, 2025 08:01AM ImmunoPrecise Antibodies (IPA) Announces Key Leadership Changes

Jan 27, 2025 08:05AM ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture

Jan 23, 2025 02:35PM Benchmark Reiterates Buy Rating on Immunoprecise Antibodies Ltd. (IPA)

Jan 22, 2025 07:02AM ImmunoPrecise Antibodies (IPA) Pioneers AI-Designed GLP-1 Therapies

Jan 17, 2025 08:01AM ImmunoPrecise Antibodies (IPA) Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles Innovation

Dec 23, 2024 08:31AM ImmunoPrecise Antibodies (IPA) Announces Insider Share Purchases

Dec 19, 2024 10:15AM IPA to Present at The Microcap Conference 2025

Dec 12, 2024 06:39AM Immunoprecise Antibodies Ltd. (IPA) PT Lowered to $7 at H.C. Wainwright

Nov 27, 2024 07:00AM DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

Nov 27, 2024 07:00AM DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

Oct 2, 2024 08:01AM ImmunoPrecise Antibodies (IPA) Signs Material Transfer Agreement with Biotheus

Aug 14, 2024 06:56AM Immunoprecise Antibodies Ltd. (IPA) PT Lowered to $3 at Benchmark

Jun 27, 2024 08:01AM ImmunoPrecise Antibodies (IPA) Appoints Kristin Taylor as CFO

Jun 25, 2024 07:03AM IPA's (IPA) Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai

Jun 10, 2024 06:16AM ImmunoPrecise Antibodies' (IPA) BioStrand Announces Immediate Commercial Offering of Software with Customizable Interface for AI-Driven Drug Discovery